Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.900 +0.040 (+0.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exscientia Ltd ADR

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning! 
Via InvestorPlace
The Latest Analyst Ratings for Exscientia
Via Benzinga
4 Analysts Have This to Say About Exscientia
Via Benzinga
Why Shares of Exscientia Soared This Week
The company benefited from a surge in interest in AI-associated stocks. 
Via The Motley Fool
Exscientia: Q1 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Via Benzinga
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
From Exscientia
Via Business Wire
3 Biotech Stocks Using AI to Change Healthcare Forever
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
Exscientia Earnings Preview
Via Benzinga
Why Shares of Exscientia Jumped on Wednesday
The company may be riding the wave of an AI healthcare boom. 
Via The Motley Fool
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours
From Exscientia plc
Via Business Wire
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Exscientia Announces Expansion of its Technology Leadership Team
From Exscientia
Via Business Wire
Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Exscientia plc
Via Business Wire
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
Via InvestorPlace
Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today
With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede. 
Via The Motley Fool
Exscientia Business Update for First Quarter 2023
From Exscientia plc
Via Business Wire
Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
From Exscientia plc
Via Business Wire
Earnings Scheduled For May 24, 2023
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion. 
Via Benzinga
Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
From Exscientia plc
Via Business Wire
Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage
From Exscientia plc
Via Business Wire
Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors
From Exscientia plc
Via Business Wire
Data Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development
From Exscientia plc
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
National Instruments, Nutex Health And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.